[1] IDF. Diabetes:A global emergency[M].7 th ed. Belgium:International Diabetes Federation,2015:11-13. [2] NCD Risk Factor Collaboration (NCD-RisC)-Africa Working Group. Worldwide trends in diabetes since 1980:a pooled analysis of 751 population-based studies with 4.4 million participants[J]. Lancet, 2016,387(10027):1513-1530. [3] 李小刚, 杨志, 黄忠明, 等. 合并与非合并糖尿病性细菌性肝脓肿的临床比较[J].中国老年学杂志, 2014,34(16):4685-4687. [4] ATREJA A,KALRA S. Infections in diabetes[J]. J Pak Med Assoc, 2015,65(9):1028-1030. [5] KNAPP S. Diabetes and infection:is there a link?-A mini-review[J]. Gerontology, 2013,59(2):99-104. [6] HOTAMISLIGIL G S. Inflammation, metaflammation and immunometabolic-disorders[J]. Nature, 2017,542(7640):177-185. [7] KANETO H, KATAKAMI N,MATSUHISA M, et al. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis[J]. Mediators Inflamm, 2010,2010:453892. [8] DASU MR,DEVARAJ S,ZHAO L, et al. High glucose induces toll-like receptor expression in human monocytes:mechanism of activation[J]. Diabetes, 2008,57(11):3090-3098. [9] TABET F,LAMBERT G,CUESTA TORRES L F, et al. Lipid-free apolipoprotein A-I and discoidal reconstituted high-density lipoproteins differentially inhibit glucose-induced oxidative stress in human macrophages[J]. Arterioscler Thromb Vasc Biol, 2011,31(5):1192-1200. [10] QUINN B J,KITAGAWA H,MEMMOTT R M, et al. Repositioning metformin for cancer prevention and treatment[J]. Trends Endocrinol Metab, 2013,24(9):469-480. [11] ISODA K,YOUNG J L,ZIRLIK A, et al. Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells[J]. Arterioscler Thromb Vasc Biol, 2006,26(3):611-617. [12] HATTORI Y,SUZUKI K,HATTORI S, et al. Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells[J]. Hypertension, 2006,47(6):1183-1188. [13] SHAW J E,SICREE R A,ZIMMET P Z. Global estimates of the prevalence of diabetes for 2010 and 2030[J]. Diabetes Res Clin Pract, 2010,87(1):4-14. [14] DRYDEN M,BAGUNEID M,ECKMANN C, et al. Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease:focus on skin and soft-tissue infections[J]. Clin Microbiol Infect, 2015,21(Suppl 2):S27-32. [15] CHEN Y C,LIN C H,CHANG S N, et al. Epidemiology and clinical outcome of pyogenic liver abscess:an analysis from the National Health Insurance Research Database of Taiwan, 2000-2011[J]. J Microbiol Immunol Infect, 2016,49(5):646-653. [16] WOHLLEBER D,KNOLLE P A. The role of liver sinusoidal cells in local hepatic immune surveillance[J]. Clin Transl Immunol, 2016,5(12):e117. [17] WANG X L,YANG C Y,ZHANG Z, et al. Ultramicrostructural study of pathological changes of capillary vessels in pulp tissues of diabetes mellitus patients[J]. Shanghai Kou Qiang Yi Xue, 2012,21(5):506-510. [18] DUSTIN M L,ROTHLEIN R,BHAN A K, et al. Induction by IL-1 and interferon-γ:tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1)[J]. J Immunol, 2011,186(9):5024-5033. [19] GALASSETTI P. Inflammation and oxidative stress in obesity, metabolic syndrome, and diabetes[J]. Exp Diabetes Res, 2012,2012:943706. [20] ESSER N,LEGRAND-POELS S,PIETTE J, et al. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes[J]. Diabetes Res Clin Pract, 2014,105(2):141-150. [21] KAUPPINEN A,SUURONEN T,OJALA J, et al. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders[J]. Cell Signal, 2013,25(10):1939-1948. |